Clinical Trial Update: Use of Topical Testosterone and Estrogen vs Estrogen Alone in Vulvodynia: a Randomized Controlled Trial [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for a Phase 2/3 study comparing topical testosterone plus estrogen versus estrogen alone in vulvodynia, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyspareunia
• Lichen Sclerosus
• Vulvodynia

Drugs mentioned

• Topical Estrogen (Estradiol) (Estradiol)
• Topical Testosterone (Testosterone)

Snippet

Sponsor: TriHealth Inc. | Conditions: Vulvodynia, Dyspareunia | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING